As of July 1, 2024, there are 105 Ozempic, Wegovy, and Rybelsus gastroparesis cases pending in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
This is the trial a regulator needs to see before broad cardiovascular labeling
Management goals are simple: reduce itch, interrupt the itchscratch cycle, and heal lesions
It takes just 2 minutes It's completely free Receive detailed Scorecard and customized assessment instantly Subscribe to Our Insights Blog Receive the latest articles from LoVasco's team of experienced experts on employee benefits and retirement plan best practices.
Primeval Labs not only wants to support their customers' goals, they want them to truly enjoy each and every product
Final thought: a Canadian case study in market exclusivity for innovative drugs This case study highlights the importance of securing a patent portfolio in Canada to utilize the patent linkage system and other regulatory tools to delay entry of generic competitors, which inevitably affects pricing across North America
